dc.contributor.author | Edghill, EL | en_US |
dc.contributor.author | Khamis, A | en_US |
dc.contributor.author | Weedon, MN | en_US |
dc.contributor.author | Walker, M | en_US |
dc.contributor.author | Hitman, GA | en_US |
dc.contributor.author | McCarthy, MI | en_US |
dc.contributor.author | Owen, KR | en_US |
dc.contributor.author | Ellard, S | en_US |
dc.contributor.author | Hattersley, AT | en_US |
dc.contributor.author | Frayling, TM | en_US |
dc.date.accessioned | 2016-08-30T08:43:07Z | |
dc.date.issued | 2011-06 | en_US |
dc.date.submitted | 2016-08-03T17:42:09.832Z | |
dc.identifier.issn | 0742-3071 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14892 | |
dc.description.sponsorship | This work was funded by the European Union (Integrated Project EURODIA LSHM-CT-2006-518153 in the Framework Programme 6 of the European Community). ATH and SE are employed as core members of the Peninsula NIHR Clinical Research Facility. KRO is an NIHR Clinician Scientist. | en_US |
dc.format.extent | 681 - 684 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | DIABETIC MED | en_US |
dc.subject | diabetes | en_US |
dc.subject | genetics | en_US |
dc.subject | polygenic | en_US |
dc.subject | variants | en_US |
dc.subject | FACTOR-I | en_US |
dc.subject | D76N POLYMORPHISM | en_US |
dc.subject | GENE | en_US |
dc.subject | MUTATIONS | en_US |
dc.subject | SUSCEPTIBILITY | en_US |
dc.subject | PANCREAS | en_US |
dc.subject | RISK | en_US |
dc.subject | IPF1 | en_US |
dc.subject | POPULATION | en_US |
dc.subject | CONTRIBUTE | en_US |
dc.title | Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes | en_US |
dc.type | Article | |
dc.rights.holder | (c) 2011 The Authors. Diabetic Medicine (c) 2011 Diabetes UK | |
dc.identifier.doi | 10.1111/j.1464-5491.2011.03269.x | en_US |
pubs.issue | 6 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 28 | en_US |